The iShares Europe ETF (ASX: IEU) gives Australians broad exposure to the largest companies across Europe — the pharmaceutical giants, luxury-goods makers, banks and industrial champions that anchor the continent’s economy. After years in which US technology dominated global returns, European equities have drawn renewed interest from investors seeking Diversification and value.

In September 2026, with US mega-cap valuations elevated and investors looking beyond America, Europe’s blue chips are back on the radar, and IEU is a leading way to access them on the ASX. This article explains how IEU works, why it is in focus, and the catalysts and risks that could shape it from here.

What is the IEU ETF?

IEU is a passive ETF issued by BlackRock under its iShares brand. It aims to provide Investment results corresponding to the performance of the S&P Europe 350 Index, before fees and expenses — a benchmark of around 350 large European companies providing geographic and sector diversity across the continent. The fund holds close to 380 stocks, is currency-unhedged, and gives Australian investors simple, diversified access to European equities in a single trade.

Because it follows a broad European index, IEU spans developed European markets — including the United Kingdom, France, Germany, Switzerland, the Netherlands and others — across sectors such as financials, industrials, healthcare, consumer goods and technology. Its holdings are anchored by globally recognised European names. The fund is currency-unhedged, so returns for Australian investors are affected by moves in the Australian dollar against the euro, British pound and other European currencies. Europe offers a different sector mix from the US, with less technology and more financials, industrials and consumer staples.

What is driving interest now?

The central theme is diversification away from expensive US mega-caps. With the US market heavily concentrated in a handful of high-valued technology giants, some investors have looked to Europe for exposure to a different set of companies, sectors and valuations. European blue chips have often traded at lower valuations than their US counterparts, which can appeal to value-oriented investors.

Europe also has its own drivers. The region is home to world-leading pharmaceutical, luxury-goods, industrial and financial companies, many of which are global businesses with revenues far beyond Europe. European monetary policy, economic growth, and the euro all feed into returns. For Australian investors, the unhedged currency exposure adds a further variable. Whether Europe continues to attract interest depends on relative valuations, earnings, and whether the long US outperformance narrows.

Portfolio and holdings

IEU’s portfolio is diversified across around 380 large European companies. Independent data has shown its largest holdings including ASML, AstraZeneca, Nestlé, Roche, Novartis, HSBC, Shell, Siemens and other European champions, with the top 10 holdings representing roughly a fifth of the fund. By sector, financials are the largest exposure, followed by industrials and healthcare, giving IEU a very different profile from the technology-heavy US market.

This composition means IEU’s returns are driven by Europe’s major banks, pharmaceutical and healthcare companies, industrial firms and consumer-goods makers. The relatively low concentration — with no single stock dominating — gives it broad diversification. Investors should understand that IEU offers exposure to a different set of sectors and companies from a US or global-technology fund, which is much of its appeal as a diversifier, though it also means it can lag when US technology leads.

Catalysts to watch

Several factors could influence IEU in the coming months: European economic growth and corporate earnings; European Central Bank Monetary Policy and its effect on the euro; whether investors continue to rotate towards Europe for diversification and value; the performance of Europe’s major pharmaceutical, luxury and industrial companies; and the AUD/EUR and AUD/GBP exchange rates for unhedged returns.

Risks

IEU carries the risks of a regional Equity fund. Region-concentration risk means its fortunes are tied to Europe’s economy. Currency risk is unhedged, so movements in the euro, pound and other currencies affect Australian-dollar returns. Sector exposure to financials, industrials and healthcare brings cyclical and regulatory risks. Europe faces its own economic and political challenges, including growth concerns and geopolitical risks. Market Risk applies. European equities can lag when US technology leads, as they have for much of the past decade.

Outlook

IEU offers Australians a simple way to diversify into Europe’s largest companies, with a sector mix quite different from the technology-heavy US market. Its near-term fortunes rest on European growth, corporate earnings, ECB policy and the currency. Investors may be watching European economic data, the euro and the relative performance of Europe versus the US for direction. The outlook may depend on whether the long US outperformance narrows and on how European companies and currencies fare for unhedged Australian investors.